March 18, 2020 / 10:37 AM / 15 days ago

BRIEF-Aurinia Announces Aurora Phase 3 Clinical Data For Voclosporin

March 18 (Reuters) - Aurinia Pharmaceuticals Inc:

* AURINIA ANNOUNCES AURORA PHASE 3 CLINICAL DATA FOR VOCLOSPORIN IN LUPUS NEPHRITIS TO BE PRESENTED AT NATIONAL KIDNEY FOUNDATION 2020 SPRING CLINICAL MEETINGS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below